x

Germany

FamiCord services are provided by eticur)

Hungary

FamiCord services are provided by Krio Intézet

Italy

FamiCord services are provided by Sorgente

Latvia

FamiCord services are provided by Climes Sunu Banka

Luxemburg

FamiCord services are provided by Stemlab

Poland

FamiCord services are provided by Polski Bank Komórek Macierzystych

Portugal

FamiCord services are provided by Crioestaminal

Romania

FamiCord services are provided by Biogenis

Spain

FamiCord services are provided by Sevibe

Switzerland

FamiCord services are provided by Stemlab

Turkey

FamiCord services are provided by Yaşam Bankası

Albania

FamiCord services are provided by Biosave

Bosnia & Herzegovina

FamiCord services are provided by Biosave

Croatia

FamiCord services are provided by Biosave

Czech Republic

FamiCord services are provided by Cekammiminko

Denmark

FamiCord services are provided by Cellaviva

Egypt

FamiCord services are provided by Cell Safe Bank

Kosovo

FamiCord services are provided by Biosave

Macedonia

FamiCord services are provided by Biosave

Montenegro

FamiCord services are provided by Biosave

Serbia

FamiCord services are provided by Biosave

Slovakia

FamiCord services are provided by Cakam Babatko

Slovenia

FamiCord services are provided by Biosave

Sweden

FamiCord services are provided by Cellaviva

Ukraine

FamiCord services are provided by UBSK

United Kingdom

FamiCord Group services are provided by Smart Cells Bank

News

FamiCord member company  won the second edition of the strategic "Prevention and treatment of diseases of civilization" - STRATEGMED

Consortium Circulate which includes Polski Bank Komórek Macierzystych (Polish Stem Cell Bank), Jagiellonian University, and many other renowned research centers won the second edition of the program organized by the National Centre for Research and Development.

Strategmed is a programme implemented by the National Centre for Research and Development at the Ministry Farm. Its main task is to stimulate the growth of innovation and competitiveness of the Polish economy. The program was addressed to Polish research consortia bringing together public research bodies and business partners. Consortia can propose their projects to combat lifestyle diseases and regenerative medicine in 4 areas:

  • cardiology and cardiac surgery
  • oncology
  • neurology and senses
  • regenerative medicine

The winning consortium  assumes the use of mesenchymal stem cells derived from the umbilical cord for the treatment of cardiovascular diseases. The project was highly evaluated and recommended for funding from the National Centre for Research and Development.